LADENBURG THALM/SH SH Lowers Celsius (NASDAQ:CELH) Price Target to $58.00

Celsius (NASDAQ:CELHGet Free Report) had its target price dropped by analysts at LADENBURG THALM/SH SH from $62.00 to $58.00 in a research note issued on Thursday,Benzinga reports. The firm currently has a “neutral” rating on the stock. LADENBURG THALM/SH SH’s price target points to a potential upside of 72.36% from the company’s previous close.

Several other brokerages also recently weighed in on CELH. Piper Sandler lowered their price objective on Celsius from $47.00 to $33.00 and set an “overweight” rating for the company in a research report on Thursday, January 23rd. Morgan Stanley reiterated an “equal weight” rating and issued a $42.00 price target on shares of Celsius in a report on Thursday, December 26th. B. Riley restated a “buy” rating and issued a $49.00 price objective (up from $44.00) on shares of Celsius in a report on Friday, February 21st. JPMorgan Chase & Co. began coverage on shares of Celsius in a research note on Thursday, December 12th. They set an “overweight” rating and a $37.00 target price on the stock. Finally, Stifel Nicolaus decreased their price objective on Celsius from $45.00 to $37.00 and set a “buy” rating for the company in a report on Monday, February 10th. One analyst has rated the stock with a sell rating, five have given a hold rating and eleven have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $44.41.

Read Our Latest Analysis on CELH

Celsius Stock Performance

CELH stock opened at $33.65 on Thursday. The firm has a market cap of $7.91 billion, a P/E ratio of 76.48, a P/E/G ratio of 2.90 and a beta of 1.90. The firm’s fifty day moving average is $26.86 and its 200 day moving average is $28.83. Celsius has a 52 week low of $21.10 and a 52 week high of $98.85.

Celsius (NASDAQ:CELHGet Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.11 by $0.03. Celsius had a return on equity of 51.89% and a net margin of 10.70%. The firm had revenue of $332.20 million for the quarter, compared to analysts’ expectations of $326.07 million. As a group, analysts forecast that Celsius will post 0.89 EPS for the current year.

Insider Activity

In other Celsius news, Director Joyce Russell sold 4,000 shares of the company’s stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $28.47, for a total value of $113,880.00. Following the completion of the transaction, the director now directly owns 19,106 shares in the company, valued at $543,947.82. This represents a 17.31 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Paul H. Storey sold 10,188 shares of the stock in a transaction dated Thursday, March 6th. The stock was sold at an average price of $25.77, for a total value of $262,544.76. Following the sale, the insider now owns 45,297 shares of the company’s stock, valued at $1,167,303.69. This represents a 18.36 % decrease in their position. The disclosure for this sale can be found here. 2.20% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Celsius

A number of institutional investors have recently added to or reduced their stakes in CELH. HM Payson & Co. increased its position in Celsius by 122.2% in the fourth quarter. HM Payson & Co. now owns 1,000 shares of the company’s stock worth $26,000 after purchasing an additional 550 shares during the last quarter. S.A. Mason LLC grew its stake in Celsius by 100.0% in the fourth quarter. S.A. Mason LLC now owns 1,400 shares of the company’s stock worth $37,000 after purchasing an additional 700 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of Celsius by 185.7% during the fourth quarter. GAMMA Investing LLC now owns 1,714 shares of the company’s stock valued at $45,000 after buying an additional 1,114 shares during the period. Blue Trust Inc. lifted its position in shares of Celsius by 32.8% in the 4th quarter. Blue Trust Inc. now owns 1,786 shares of the company’s stock worth $47,000 after purchasing an additional 441 shares during the period. Finally, Knuff & Co LLC purchased a new position in shares of Celsius in the 4th quarter valued at $50,000. 60.95% of the stock is owned by hedge funds and other institutional investors.

About Celsius

(Get Free Report)

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.

Recommended Stories

Analyst Recommendations for Celsius (NASDAQ:CELH)

Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.